Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6353777-01 0.2 mL
TAX1BP1, ID (TAX1BP1, T6BP, Tax1-binding protein 1, TRAF6-binding protein) (APC)
Sign In for Pricing
View Details 
MBS6353777-02 5x 0.2 mL
TAX1BP1, ID (TAX1BP1, T6BP, Tax1-binding protein 1, TRAF6-binding protein) (APC)
Sign In for Pricing
View Details 480177 100 µL
EMX1 (Homeobox Protein EMX1, Empty Spiracles Homeobox 1)
Sign In for Pricing
View Details 